Cathie Wood says AI in one big field is the 'sleeper' opportunity Wall Street is missing (www.businessinsider.com)

At the All‑In Summit 2025, Ark Invest CEO Cathie Wood argued that healthcare is the overlooked “sleeper” for AI-driven returns, saying the biggest real‑world revolution won’t be chatbots or autonomous cars but AI applied inside hospitals and labs. She highlighted that AI’s payoff is being underpriced by investors even as Wall Street chases front‑end consumer playbooks; Wood pointed to the convergence of five steep‑growth technologies—AI, robotics, energy storage, blockchain and genomics—as the multiplier that will accelerate breakthroughs and create outsized investment opportunities. Technically, Wood emphasized how smarter algorithms, cheaper high‑throughput gene sequencing and advances in CRISPR gene editing form a feedback loop: better AI speeds sequencing and analysis, more genomic data improves models, and gene‑editing breakthroughs enable novel therapeutics. Big tech is already staking claims—Microsoft has integrated AI into clinical workflows and reported an AI system outperforming physicians in a study, while Nvidia is targeting medical imaging and has partnerships (e.g., GE Healthcare). The implication for AI/ML practitioners and investors is clear: healthcare offers high‑leverage, clinically meaningful problems that demand domain‑aware models, large labeled biological datasets, and regulatory‑savvy deployment—areas that could produce both scientific impact and significant market value if the ecosystem matures.